Literature DB >> 7584959

Purification and expansion of human Schwann cells in vitro.

J L Rutkowski1, C J Kirk, M A Lerner, G I Tennekoon.   

Abstract

The ability to culture cells from the human nervous system provides new insight into the pathophysiology of neurological diseases and could be crucial to the development of gene replacement therapies and neural transplantation. We report that the proliferation of human Schwann cells isolated from paediatric and adult nerves is sustained in vitro by recombinant glial growth factor. Agents that increase intracellular cyclic cAMP were also mitogenic towards Schwann cells but suppress growth of contaminating fibroblasts. As the lifespan of highly enriched cultures can be extended for up to twelve population doublings, large numbers of cells can be generated from nerve biopsies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584959     DOI: 10.1038/nm0195-80

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  30 in total

Review 1.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

Review 2.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 3.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

Review 4.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

5.  Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins.

Authors:  J B Grinspan; M A Marchionni; M Reeves; M Coulaloglou; S S Scherer
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

6.  Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.

Authors:  D Muir; D Neubauer; I T Lim; A T Yachnis; M R Wallace
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

7.  Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.

Authors:  Haruo Kanno; Yelena Pressman; Alison Moody; Randall Berg; Elizabeth M Muir; John H Rogers; Hiroshi Ozawa; Eiji Itoi; Damien D Pearse; Mary Bartlett Bunge
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

8.  Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth.

Authors:  N K Mahanthappa; E S Anton; W D Matthew
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

9.  Engineered Tissues Made from Human iPSC-Derived Schwann Cells for Investigating Peripheral Nerve Regeneration In Vitro.

Authors:  Rebecca Powell; James B Phillips
Journal:  Methods Mol Biol       Date:  2021

10.  Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system.

Authors:  C Bachelin; V Zujovic; D Buchet; J Mallet; A Baron-Van Evercooren
Journal:  Brain       Date:  2009-10-20       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.